Carboxypeptidase A2/CPA2 Antibody (30) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89531V
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 30
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human Carboxypeptidase A2/CPA2 (Accession#: NP_001859.1; Met 1-Tyr 417).
Specificity
No cross-reactivity in ELISA with:
Human CPA1 / Carboxypeptidase A1
Human CPE / Carboxypeptidase E
Human Carboxypeptidase B1 / CPB1 / PCPB
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Carboxypeptidase A2/CPA2 Antibody (30) [DyLight 405]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Carboxypeptidase A2/CPA2
Alternate Names
CPA2
Gene Symbol
CPA2
Additional Carboxypeptidase A2/CPA2 Products
Product Documents for Carboxypeptidase A2/CPA2 Antibody (30) [DyLight 405]
Product Specific Notices for Carboxypeptidase A2/CPA2 Antibody (30) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...